Three months into my role as CEO of BioNTX, I continue to be energized by the people, partnerships, and possibilities that define our North Texas life sciences ecosystem. My first priority has been simple: listen, learn, and engage with the extraordinary innovators, entrepreneurs, researchers, healthcare leaders, and partners who make this region one of the most dynamic in the country.

What I've discovered is a community with tremendous momentum and an even greater willingness to collaborate. That spirit of partnership is one of North Texas' greatest strengths and one that BioNTX is uniquely positioned to cultivate.

That momentum was reinforced during the recent BIO International Convention in San Diego, where BioNTX joined thousands of leaders from around the world to showcase the extraordinary progress taking place across North Texas. BIO provided an important reminder that while biotechnology is a global enterprise, innovation ecosystems are built locally through trusted relationships, strategic partnerships, and organizations willing to bring people together around a shared vision.

The conversations in San Diego also underscored something we see every day at home: North Texas is increasingly recognized as one of the nation's most exciting and collaborative life science regions. Our growing capabilities in biotechnology, healthcare innovation, artificial intelligence, advanced therapeutics, diagnostics, and commercialization position us to play an even greater role in shaping the future of our industry.

As we look ahead, that energy continues with the 2026 iC³ Life Science & Healthcare Innovation Summit this September. More than an annual event, iC³ is an opportunity to convene leaders across industry, academia, healthcare, investment, and government to explore emerging ideas, forge new partnerships, and strengthen the innovation ecosystem that defines our region.

BioNTX is proud to serve as a connector within that ecosystem, creating opportunities for collaboration while elevating the groundbreaking work happening across North Texas. As our industry continues to evolve, our commitment remains the same: bringing together the people and organizations whose collective efforts accelerate innovation and improve lives.

I am grateful for the warm welcome I have received during these first few months and excited about the journey ahead. Together, we have an incredible opportunity to build on our momentum, strengthen our connections, and continue positioning North Texas as a leader in life science and healthcare innovation.

I look forward to seeing many of you at iC³ this September as we continue shaping the future together.

Sincerely,

Gina Ford, DPh, MBA

CEO, BioNTX

As BioNTX reflects on its experience at the BIO International Convention in San Diego, one message rises above all others: the future of biotechnology will be shaped not only by scientific breakthroughs, but by the strength of the innovation ecosystems that make those breakthroughs possible. Across keynote sessions, industry discussions, and conversations with leaders from around the world, three themes emerged that are particularly relevant to North Texas.

1. Innovation Depends On Strong Ecosystems: The biotechnology industry was built through collaboration among research institutions, entrepreneurs, investors, industry, and government. That model remains as important today as it was fifty years ago. Speakers emphasized that public research funding, private investment, academic discovery, and commercialization are complementary forces. Maintaining America’s leadership in biotechnology will require continued investment across this entire ecosystem. For North Texas, this reinforces the importance of organizations like BioNTX, which bring together the people and institutions responsible for turning discovery into impact.
2. Capital Is Returning, But Expectations Are Higher: The investment environment continues to improve, but investors are becoming increasingly selective. Capital is flowing toward companies with strong science, disciplined execution, and clear clinical milestones. Emerging biotechnology companies continue to drive the majority of innovation, yet today’s investment climate rewards quality over quantity. Success increasingly depends on demonstrating scientific rigor, strategic focus, and the ability to translate innovation into measurable outcomes.
3. Global Competition Is Accelerating: Countries around the world are making long-term investments designed to strengthen their biotechnology sectors, underscoring the importance of sustained commitment to research, workforce development, and policies that encourage innovation in the United States. For North Texas, this represents both an opportunity and a responsibility. The region has the research institutions, healthcare systems, entrepreneurial talent, and collaborative culture to compete on a global stage. Continuing to strengthen those connections will be essential to maintaining momentum.

CleanSpace is emphasizing the growing complexity of life sciences facility development as therapies become more advanced and regulatory requirements continue to increase. In a recent perspective shared with the Philadelphia Business Journal, the company highlights how these evolving demands are reshaping how organizations approach facility planning and long-term operational risk. The company notes that fragmented project delivery models can create gaps across planning, design, construction, and operations, potentially impacting facility performance, compliance, and reliability well beyond project completion.

Turner has been ranked the nation’s top healthcare construction manager by Modern Healthcare, marking the 25th time in 29 years the company has received the top position. The ranking is based on annual healthcare construction volume. With a century-long history in healthcare construction dating back to 1925, Turner continues to deliver hospitals, research facilities, and specialty care centers focused on improving patient care and operational performance. The recognition underscores its long-standing role in shaping healthcare infrastructure across the United States.

Cook Children’s Medical Center Prosper has expanded neonatal care capacity and is working toward higher-level designations for both its NICU and trauma center to better serve North Texas families. The hospital opened its NICU in September 2025, featuring 11 beds across private and twin-capable rooms, and is now pursuing Level III designation for both services. This upgrade would allow more critically ill newborns and trauma patients to receive advanced care locally, reducing the need for transfers to Fort Worth.